ArticleMultidisciplinary respiratory medicine2014
Effectiveness of pharmacologic therapies on smoking cessation success: three years results of a smoking cessation clinic.
Article in Multidisciplinary respiratory medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Efficacy and Safety of Cytisine in Combination with a Community Pharmacists' Counselling for Smoking Cessation in Thailand: A Randomized Double-Blinded Placebo-Controlled Trial.International journal of environmental research and public health · 2022Trial
- Patient-Level Determinants Outweigh Pharmacotherapy Choice in Smoking Cessation: Evidence from a Real-World Study in Turkey.Healthcare (Basel, Switzerland) · 2026Article
- The Impact of Breast Reconstruction on Smoking Cessation Among Patients With Breast Cancer.Journal of surgical oncology · 2026Article
- Evaluation of Smoking Cessation Success Rate and Its Effective Factors in Patients Referring to the Smoking Cessation Clinic of Farshchian Specialized Heart Hospital in Hamadan, Iran.Addiction & health · 2026Article
- Factors Associated with Successful Smoking Cessation Among Adults in Saudi Arabia-A Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2025Article
- Cytisine compared to combination nicotine replacement therapy to reduce cigarette consumption in relapsed smokers: protocol for a pilot randomized controlled trial.Pilot and feasibility studies · 2025Article
- Assessment of smoking cessation outcomes in patients with cardiovascular disease: A retrospective cohort study from Türkiye.Tobacco induced diseases · 2025Article
- Factors Associated with Relapses in Alcohol and Substance Use Disorder.The Eurasian journal of medicine · 2023Article
- Effectiveness of smoking cessation interventions for smokers with Crohn's disease: a systematic review.Future science OA · 2023Review
- Pharmacological smoking cessation of adults aged 30-50 years with COPD.NPJ primary care respiratory medicine · 2022Article
- Evaluating level of adherence to nicotine replacement therapy and its impact on smoking cessation: a systematic review and meta-analysis.Archives of public health = Archives belges de sante publique · 2021Review
- Article
- Nicotine dependence treatment: provision of a dedicated programme by the National Addictions Management Service.Singapore medical journal · 2020Article
- The effect of a multidisciplinary approach for smoking cessation in patients with Crohn's disease: Results from an observational cohort study.Tobacco induced diseases · 2020Article
- Healthcare Costs of Smokers Using Varenicline Versus Nicotine-Replacement Therapy Patch in the United States: Evidence from Real-World Practice.Advances in therapy · 2019Article
- Tobacco Control Policies in Turkey in Terms of MPOWER.The Eurasian journal of medicine · 2019Review
- Comparison of monoamine oxidase inhibition by cigarettes and modified risk tobacco products.Toxicology reports · 2019Article
- Effects of lorcaserin (BelviqDrug and alcohol dependence · 2017Article
- Gender differences in the real-world effectiveness of smoking cessation medications: Findings from the 2010-2011 Tobacco Use Supplement to the Current Population Survey.Drug and alcohol dependence · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPharmacologic therapies have an important role in the success of interventions for smoking cessation. This study aims to determine the efficacy of several pharmacologic treatments in patients who applied to a smoking cessation clinic.
methodsThis retrospective study includes 422 patients who presented to our smoking cessation clinic between January 2010 and June 2013, used the pharmacologic treatment as prescribed and completed the one-year follow-up period. All patients were assessed using the Fagerström Test for Nicotine Dependence (FTND) and received both behavioral therapy and pharmacotherapy. Patients' smoking status at one year was assessed by telephone interview.
resultsThe patients were 24.3% female (103/422) and 75.7% male (319/422) with a mean age of 38 ± 10 years. Patients were divided into three groups: varenicline (166 patients), bupropion (148 patients) and nicotine replacement therapy (108 patients).The smoking cessation rates of these groups were 32.5%, 23% and 52.8%, respectively, and were statistically significant (p > 0.001). The overall success rate was 35%. Further analysis revealed that pharmacologic therapy (p > 0.001) and gender (p = 0.01) were factors that showed statistically significant effects on smoking cessation rates. Males had higher success rates than females. The overall relapse rate was 21.6% and the bupropion group showed the highest relapse rate among treatment groups. Lack of determination emerged as the most important factor leading to relapse.
conclusionNicotine replacement therapy was found to be more effective at promoting abstinence from smoking than other pharmacologic therapies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.